679 related articles for article (PubMed ID: 24917030)
21. Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
Bozzetti C; Quaini F; Squadrilli A; Tiseo M; Frati C; Lagrasta C; Azzoni C; Bottarelli L; Galetti M; Alama A; Belletti S; Gatti R; Passaro A; Gradilone A; Cavazzoni A; Alfieri R; Petronini PG; Bonelli M; Falco A; Carubbi C; Pedrazzi G; Nizzoli R; Naldi N; Pinto C; Ardizzoni A
PLoS One; 2015; 10(11):e0142891. PubMed ID: 26571236
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.
Hyun KA; Kwon K; Han H; Kim SI; Jung HI
Biosens Bioelectron; 2013 Feb; 40(1):206-12. PubMed ID: 22857995
[TBL] [Abstract][Full Text] [Related]
23. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
[TBL] [Abstract][Full Text] [Related]
24. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
25. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
[TBL] [Abstract][Full Text] [Related]
26. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
27. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
Hyun KA; Lee TY; Lee SH; Jung HI
Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
[TBL] [Abstract][Full Text] [Related]
28. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
[TBL] [Abstract][Full Text] [Related]
30. Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cells.
Yoo CE; Moon HS; Kim YJ; Park JM; Park D; Han KY; Park K; Sun JM; Park WY
Biomaterials; 2016 Jan; 75():271-278. PubMed ID: 26513419
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
[TBL] [Abstract][Full Text] [Related]
32. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
Pugia M; Magbanua MJM; Park JW
Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
[TBL] [Abstract][Full Text] [Related]
33. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
[TBL] [Abstract][Full Text] [Related]
34. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
35. Highly efficient capture and harvest of circulating tumor cells on a microfluidic chip integrated with herringbone and micropost arrays.
Xue P; Wu Y; Guo J; Kang Y
Biomed Microdevices; 2015 Apr; 17(2):39. PubMed ID: 25749640
[TBL] [Abstract][Full Text] [Related]
36. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
37. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P
Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699
[TBL] [Abstract][Full Text] [Related]
38. Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ
Myung JH; Cha A; Tam KA; Poellmann M; Borgeat A; Sharifi R; Molokie RE; Votta-Velis G; Hong S
Anal Chem; 2019 Jul; 91(13):8374-8382. PubMed ID: 31247718
[TBL] [Abstract][Full Text] [Related]
39. Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration.
Pugia M; Magbanua MJM; Park JW
Adv Exp Med Biol; 2017; 994():119-131. PubMed ID: 28560671
[TBL] [Abstract][Full Text] [Related]
40. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]